The review summarizes the data on the metabolic potential of methanotrophs as producers of biopolymers, alternative biofuel, bioprotectants, and other secondary metabolites. The work provides the examples of modern ‘omic’ technologies used for genetic engineering of efficient methanotrophic producers.
No takes yet. Share an insight, caveat, or question.
Khmelenina et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: